Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model.

Faisal SM, Chen JW, Yan F, Chen TT, Useh NM, Yan W, Guo S, Wang SJ, Glaser AL, McDonough SP, Singh B, Davis WC, Akey BL, Chang YF.

Clin Vaccine Immunol. 2013 Apr;20(4):572-81. doi: 10.1128/CVI.00653-12. Epub 2013 Feb 13.

2.

Evaluation of a Salmonella vectored vaccine expressing Mycobacterium avium subsp. paratuberculosis antigens against challenge in a goat model.

Faisal SM, Yan F, Chen TT, Useh NM, Guo S, Yan W, Wang SJ, Glaser AL, McDonough SP, Singh B, Chang YF.

PLoS One. 2013 Aug 9;8(8):e70171. doi: 10.1371/journal.pone.0070171. eCollection 2013.

3.

Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.

Park KT, Allen AJ, Bannantine JP, Seo KS, Hamilton MJ, Abdellrazeq GS, Rihan HM, Grimm A, Davis WC.

Vaccine. 2011 Jun 24;29(29-30):4709-19. doi: 10.1016/j.vaccine.2011.04.090. Epub 2011 May 10.

4.

Immunogenicity and protective efficacy of the Mycobacterium avium subsp. paratuberculosis attenuated mutants against challenge in a mouse model.

Chen JW, Faisal SM, Chandra S, McDonough SP, Moreira MA, Scaria J, Chang CF, Bannantine JP, Akey B, Chang YF.

Vaccine. 2012 Apr 19;30(19):3015-25. doi: 10.1016/j.vaccine.2011.11.029. Epub 2011 Nov 19.

PMID:
22107851
5.
7.

Evaluation of novel oral vaccine candidates and validation of a caprine model of Johne's disease.

Hines ME 2nd, Turnquist SE, Ilha MR, Rajeev S, Jones AL, Whittington L, Bannantine JP, Barletta RG, Gröhn YT, Katani R, Talaat AM, Li L, Kapur V.

Front Cell Infect Microbiol. 2014 Mar 4;4:26. doi: 10.3389/fcimb.2014.00026. eCollection 2014.

8.

Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice.

Bannantine JP, Everman JL, Rose SJ, Babrak L, Katani R, Barletta RG, Talaat AM, Gröhn YT, Chang YF, Kapur V, Bermudez LE.

Front Cell Infect Microbiol. 2014 Jul 1;4:88. doi: 10.3389/fcimb.2014.00088. eCollection 2014.

9.

Efficacy of spheroplastic and cell-wall competent vaccines for Mycobacterium avium subsp. paratuberculosis in experimentally-challenged baby goats.

Hines ME 2nd, Stiver S, Giri D, Whittington L, Watson C, Johnson J, Musgrove J, Pence M, Hurley D, Baldwin C, Gardner IA, Aly S.

Vet Microbiol. 2007 Mar 10;120(3-4):261-83. Epub 2006 Oct 29.

PMID:
17123751
10.

Immune response and protective efficacy of live attenuated Salmonella vaccine expressing antigens of Mycobacterium avium subsp. paratuberculosis against challenge in mice.

Chandra S, Faisal SM, Chen JW, Chen TT, McDonough SP, Liu S, Moreira MA, Akey BL, Chang CF, Chang YF.

Vaccine. 2012 Dec 17;31(1):242-51. doi: 10.1016/j.vaccine.2012.09.024. Epub 2012 Sep 20.

PMID:
23000222
11.

Mediation of host immune responses after immunization of neonatal calves with a heat-killed Mycobacterium avium subsp. paratuberculosis vaccine.

Stabel JR, Waters WR, Bannantine JP, Lyashchenko K.

Clin Vaccine Immunol. 2011 Dec;18(12):2079-89. doi: 10.1128/CVI.05421-11. Epub 2011 Oct 26.

12.

Evaluation of the cell-mediated immune response to reduced doses of Mycobacterium avium ssp. paratuberculosis vaccine in cattle.

Platt R, Thoen CO, Stalberger RJ, Chiang YW, Roth JA.

Vet Immunol Immunopathol. 2010 Jul;136(1-2):122-6. doi: 10.1016/j.vetimm.2010.02.003. Epub 2010 Feb 11.

PMID:
20193967
13.
14.

Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis.

Kathaperumal K, Kumanan V, McDonough S, Chen LH, Park SU, Moreira MA, Akey B, Huntley J, Chang CF, Chang YF.

Vaccine. 2009 Jan 1;27(1):123-35. doi: 10.1016/j.vaccine.2008.10.019. Epub 2008 Oct 26.

PMID:
18955101
15.

Mycobacterium avium subsp. paratuberculosis antibody response, fecal shedding, and antibody cross-reactivity to Mycobacterium bovis in M. avium subsp. paratuberculosis-infected cattle herds vaccinated against Johne's disease.

Tewari D, Hovingh E, Linscott R, Martel E, Lawrence J, Wolfgang D, Griswold D.

Clin Vaccine Immunol. 2014 May;21(5):698-703. doi: 10.1128/CVI.00032-14. Epub 2014 Mar 12.

16.

Attenuated strains of Mycobacterium avium subspecies paratuberculosis as vaccine candidates against Johne's disease.

Settles EW, Kink JA, Talaat A.

Vaccine. 2014 Apr 11;32(18):2062-9. doi: 10.1016/j.vaccine.2014.02.010. Epub 2014 Feb 22.

PMID:
24565753
17.

Deletion of relA abrogates the capacity of Mycobacterium avium paratuberculosis to establish an infection in calves.

Park KT, Allen AJ, Barrington GM, Davis WC.

Front Cell Infect Microbiol. 2014 May 15;4:64. doi: 10.3389/fcimb.2014.00064. eCollection 2014.

18.

Cell-mediated and humoral immune responses after immunization of calves with a recombinant multiantigenic Mycobacterium avium subsp. paratuberculosis subunit vaccine at different ages.

Thakur A, Aagaard C, Stockmarr A, Andersen P, Jungersen G.

Clin Vaccine Immunol. 2013 Apr;20(4):551-8. doi: 10.1128/CVI.05574-11. Epub 2013 Feb 6.

19.

Immunization with DNA vaccines encoding different mycobacterial antigens elicits a Th1 type immune response in lambs and protects against Mycobacterium avium subspecies paratuberculosis infection.

Sechi LA, Mara L, Cappai P, Frothingam R, Ortu S, Leoni A, Ahmed N, Zanetti S.

Vaccine. 2006 Jan 16;24(3):229-35. Epub 2005 Sep 8.

PMID:
16183174
Items per page

Supplemental Content

Write to the Help Desk